Selfreported physical violence through nursing students while basic scientific studies

a promising predictors of cardiovascular iron load and, decreased LVEF-3D, FMD, and aortic strain might be good indicators of subclinical cardiovascular involvement of β-TM.
Erectile dysfunction (ED) is a condition that is very common all over the world, concerns about men and causes very important social problems. The aim of this study is to perform quantitative penile corpus cavernosum (CC) stiffness measurements by using SWE for patients with both types of vascular ED.
In our study, we handled the data of 101 participants in total. The average age of the participants was 56.36. We divided the participants after color Doppler US (CDUS) into three groups normal group (n=30), arterial insufficiency (n=51), and venous insufficiency (n=20). SWE measurements were made in both groups in the CC flaccid (f) and rigid (r) positions, and the results were noted. International Index of Erectile Function (IIEF-5) questionnaire and Erection score (ES) were evaluated.
The mean CC f SWE and r SWE measurement values were 20.2 ± 0.8 and 17.15± 0.54kPa, 3.84 ± 0.13 and 2.78 ± 0.11m/s in the arterial insufficiency group; 15.72 ± 0.58 and 12.52 ± 0.33kPa, 2.88 ± 0.06 and 2.09 ± 0.11m/s in the venous insufficiency group; 14.75 ± 0.51 and 13.41 ± 0.36kPa, 2.63 ± 0.1 and 2.34 ± 0.11m/s in the control group, respectively. The CC measurement of f SWE and r SWE values as kPa showed significant differences between the groups (P < .001).
SWE can provide quantitative data with high specificity and sensitivity while evaluating CC penile stiffness noninvasively. It seems to contribute to the radiological evaluation of ED cases with useful data.
SWE can provide quantitative data with high specificity and sensitivity while evaluating CC penile stiffness noninvasively. It seems to contribute to the radiological evaluation of ED cases with useful data.
We aimed to evaluate the utility of the preprocedural platelet-lymphocyte ratio (PLR) for predicting the no-reflow phenomenon after thrombus aspiration during percutaneous coronary intervention (PCI) in patients with ST-segment elevation myocardial infarction (STEMI).
We retrospectively analyzed postprocedural thrombolysis in myocardial infarction (TIMI) flow grades and myocardial blush grades (MBG) of 247 patients who underwent a PCI procedure with thrombus aspiration.We divided these patients into two groups according to whether they had no-reflow (TIMI<3, MBG<2) or not (TIMI 3, MBG≥2).
No-reflow developed in 43 (17%) patients.Preprocedural PLR was significantly higher in the no-reflow group (183.76±56.65 vs 118.32±50.42 p<0.001).Independent predictors of no-reflow were as follows higher preprocedural platelet-lymphocyte ratio (PLR) (OR=1.018; 95% CI=1.004, 1.033; p=0.013),mean corpuscular volume (MCV) (OR=1.118; 95% CI=1.024, 1.220; p=0.012) and SYNTAX Score-2 (OR=1.073; 95% CI=1.005, 1.146; p=0.036). PLR of 144 had 79% sensitivity and 75% specificity for the prediction of no-reflow.
PLR is a reliable predictor for no-reflow in STEMI patients undergoing thrombus aspiration.
PLR is a reliable predictor for no-reflow in STEMI patients undergoing thrombus aspiration.
What is the central question of this study? To what extent does testosterone influence haemoglobin formation during male puberty? What is the main finding and its importance? In boys, testosterone might be responsible for about 65% of the increase in haemoglobin mass during puberty. The underlying mechanisms are assumed to be twofold (i) indirectly, mediated by the increase in lean body mass, and (ii) directly by immediate testosterone effects on erythropoiesis. Thereby, an increase in testosterone of 1ng/ml is associated with an increase in haemoglobin mass of ∼65g. These processes are likely to determine endurance performance in adulthood.
The amount of haemoglobin during puberty is related to endurance performance in adulthood. During male puberty, testosterone stimulates erythropoiesis and could therefore be used as a marker for later endurance performance. This cross-sectional study aimed to determine the relationship between serum testosterone concentration and haemoglobin mass (Hbmass) in both males measured by ELISA. Hbmass was determined by CO-rebreathing. Haemoglobin concentration did not change during maturation in girls and was 11% higher during puberty in boys, while Hbmass was elevated by 33% in Tanner stage V compared to stage II in girls (498 ± 77 vs. 373 ± 88 g) and by 95% in boys (832 ± 143 vs. 428 ± 95 g). This difference can most likely be attributed to indirect testosterone influences through an increase in lean body mass (LBM) and to direct testosterone effects on erythropoiesis, which increase the Hbmass by ∼65 g per 1 ng/ml. Altitude and training statuses were not associated with testosterone, but with an increase in Hbmass (altitude by 1.1 g/kg LBM, training by 0.8 g/kg LBM). Changes in Hbmass are closely related to testosterone levels during male puberty. Further studies will show whether testosterone and Hbmass during childhood and adolescence can be used as diagnostic tools for endurance talents.Hyperviscosity syndrome (HVS) is a life-threatening syndrome caused by high concentrations of large plasma proteins like IgM, rheumatoid factor, and other immune complexes, leading to increased blood viscosity and symptoms such as visual abnormalities, neurological impairment, bleeding diathesis, and thrombosis. While Waldenström's macroglobulinemia accounts for 80% to 90% of cases, HVS may develop in other clinical settings characterized by elevations in plasma proteins. Limited evidence currently exists describing the safety and efficacy of therapeutic plasma exchange (TPE) for the management of HVS secondary to non-neoplastic conditions. selleck kinase inhibitor We report a case of recurrent HVS associated with juvenile rheumatoid arthritis and Felty syndrome that demonstrated improvement in clinical symptoms following initiation of TPE. These findings suggest that TPE may be utilized as an adjunct treatment option in patients with HVS secondary to autoimmune disorders.